Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab Continuing PBS authority application Supporting information form (PB125)

You must lodge this form for a patient receiving one of the following Pharmaceutical Benefits Scheme (PBS) subsidised treatment with eculizumab for continuing treatment.


Page last updated: 22 April 2016

This information was printed Saturday 1 October 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.